Navigation Links
ULURU Inc. Announces the Launch of the Altrazeal(TM) Website
Date:11/4/2008

- New Site Provides Extensive Information to Patients and Physicians -

ADDISON, Texas, Nov. 4 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it has launched a new Altrazeal(TM) website designed to provide information to both health care professionals and patients on the clinical benefits of Altrazeal(TM).

In addition to product information, demonstration of the use of Altrazeal(TM) and product attributes and benefits, the website includes patient testimonials and clinical case studies. As further product information becomes available this will be added to the website including a video of the Satellite Symposium "Altrazeal(TM) - Transforming Clinical Wound Management - From Science to Outcomes with an Innovative Powder Dressing", which was held on October 29, 2008. It is anticipated that this will be available by November 15, 2008.

Altrazeal(TM), a transforming powder dressing, which is produced using our Nanoflex(TM) Technology, is a breakthrough new treatment for exuding wounds including burns, trauma, skin graft donor sites, surgical wounds and chronic slow-healing wounds such as diabetic foot ulcers, pressure ulcers and venous ulcers. Altrazeal(TM) is designed for greater effectiveness in wound closure by promoting an optimal moist wound healing environment. Altrazeal(TM) provides additional patient benefits including reduced pain and enhanced patient comfort, ease of application and removal and, in most cases, it does not require a secondary dressing.

Commenting on the new website, Renaat Van Den Hooff, Executive Vice President Operations of ULURU, stated, "The most important objective of the website is to provide both patients and health care professionals with the most comprehensive and up to date information for obtaining the best clinical results and patient satisfaction with Altrazeal(TM). Also, we plan to add new patient testimonials and clinical case studies that will demonstrate the significant patient benefit being generated by this game-changing new treatment for exuding wounds. By providing this information we believe patient's outcomes will be maximized and the science of treating wounds will continue to advance."

About ULURU Inc.:

ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Nanoflex(TM) Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the response to the product from patients, the importance of use of the product for burn victims, the ability to use the product for chronic wounds, the perception of the product as a transformational innovation in the wound care market, the product accelerates healing and decreases pain and decreases dressing changes. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007, Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company Media Contact:

Kerry P. Gray Stephen Zoegall, Ph.D.

President & CEO Berry & Co. Public Relations

Terry K. Wallberg (212) 253-8881

Vice President & CFO szoegall@berrypr.com

(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
2. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
3. ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008
4. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
5. ULURU Inc. Reports First Quarter 2008 Financial Results
6. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
9. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
10. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
11. ULURU Inc. Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
(Date:6/23/2016)...  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member.  ... president and chief scientific officer, Mallinckrodt Pharmaceuticals, will ... Board of Directors. ... us in support of our efforts to conduct ...
Breaking Medicine Technology: